Hong Kong· Hong Kong
First report 19m ago•Last update 19m ago

Hong Kong biotechnology stocks under pressure

Biotechnology stocks listed in Hong Kong are experiencing a downturn, with the Hang Seng Biotech Index falling by over 3%.

Background

Hong Kong operates under a 'One Country, Two Systems' framework, granting it a high degree of autonomy except in defense and foreign affairs. This unique status has fostered a dynamic financial market, but also led to ongoing political tensions regarding its relationship with mainland China. These tensions often influence various sectors, including its economy and regulatory environment.

Quorum · collective opinions

Hong Kong biotechnology stocks under pressure

First report 22h agoLast update 22h ago
1 takes▼ 1

iWitness comments

No comments yet — be the first to weigh in.